Korean Stock Flows

Hans Biomed (KRX: 042520)

한스바이오메드 KOSDAQ Biotech & Pharma 의료용품 및 기타 의약 관련제품 제조업
Close (Oct 16, 2026)
₩21,800
+25.36%
Market cap
₩0T ($0.2B)
52-week range
₩15,300 – ₩57,800
P/E (12M fwd) · P/B · Div yield
12.21 · 8.75 · 0%
trailing – · consensus of 1 analysts

Who is buying Hans Biomed?

Between Sep 15, 2026 and Oct 16, 2026 (20 trading sessions), foreign investors net bought ₩0.1bn ($0M) of Hans Biomed, the 557th largest foreign net purchase among 1828 KOSDAQ stocks. Institutions net bought ₩3.7bn ($3M) and retail investors net sold ₩3.7bn ($3M) over the same window. Foreigners were net buyers on 8 of the 20 sessions.

Foreign investors hold 6% of Hans Biomed's listed shares (KRX ownership data as of Oct 16, 2026), down from 6.12% twenty sessions earlier and 2.19% a year ago.

The stock closed at ₩21,800 on Oct 16, 2026: +12.08% over 20 sessions, -21.01% year-to-date, -13.83% over one year. The 52-week range is ₩15,300 – ₩57,800.

At ₩21,800 the stock trades at 12.21× 12-month-forward consensus earnings (1 analysts).

Hans Biomed share price, last 60 trading days (KRW)
24,631 21,947 19,263 16,579 Jul 16 Aug 31 Oct 16
Daily foreign investor net purchases, last 60 trading days
+1.3bn +0.7bn -0.7bn -1.3bn Jul 16 Aug 31 Oct 16
View chart data as a table
Date Close Foreign net Institutions Retail
2026-10-16 ₩21,800 +₩0.9bn +₩1.9bn ₩-2.7bn
2026-10-15 ₩17,390 ₩-0.4bn ₩-0.3bn +₩0.7bn
2026-10-14 ₩19,100 +₩0.3bn ₩-0.9bn +₩0.3bn
2026-10-13 ₩19,930 ₩-0.6bn +₩0.6bn ₩-0.1bn
2026-10-12 ₩19,940 ₩-0.1bn +₩0.5bn ₩-0.4bn
2026-10-08 ₩20,650 ₩-0.6bn ₩-0.4bn +₩1.1bn
2026-10-07 ₩22,600 ₩-0.4bn +₩0.1bn +₩0.3bn
2026-10-06 ₩22,250 ₩-0.4bn +₩0.5bn ₩-0.0bn
2026-10-02 ₩21,250 ₩-0.4bn +₩0.3bn +₩0.2bn
2026-10-01 ₩22,550 +₩1.3bn +₩0.8bn ₩-2.0bn
2026-09-30 ₩20,750 +₩0.1bn +₩0.6bn ₩-0.7bn
2026-09-29 ₩21,050 +₩0.8bn +₩1.2bn ₩-2.1bn
2026-09-28 ₩18,010 ₩-0.1bn +₩0.4bn ₩-0.3bn
2026-09-23 ₩17,780 +₩0.1bn +₩0.1bn ₩-0.2bn
2026-09-22 ₩17,320 ₩-0.3bn ₩-0.2bn +₩0.5bn
2026-09-21 ₩17,720 ₩-0.4bn +₩0.0bn +₩0.4bn
2026-09-18 ₩18,120 ₩-0.3bn +₩0.1bn +₩0.2bn
2026-09-17 ₩18,160 +₩0.3bn ₩-0.6bn +₩0.3bn
2026-09-16 ₩18,620 +₩0.3bn ₩-0.5bn +₩0.2bn
2026-09-15 ₩18,900 ₩-0.2bn ₩-0.4bn +₩0.6bn
2026-09-14 ₩19,450 +₩0.1bn +₩0.0bn ₩-0.2bn
2026-09-11 ₩19,730 +₩0.1bn ₩-0.2bn +₩0.1bn
2026-09-10 ₩20,100 ₩-0.3bn ₩-0.1bn +₩0.4bn
2026-09-09 ₩21,100 ₩-0.7bn +₩0.5bn +₩0.1bn
2026-09-08 ₩21,200 +₩0.1bn +₩1.1bn ₩-1.2bn
2026-09-07 ₩19,600 ₩-0.4bn +₩0.4bn ₩-0.1bn
2026-09-04 ₩19,630 ₩-0.2bn +₩0.2bn ₩-0.0bn
2026-09-03 ₩19,330 ₩-0.6bn +₩0.5bn +₩0.0bn
2026-09-02 ₩19,900 ₩0.0bn +₩0.3bn ₩-0.3bn
2026-09-01 ₩20,200 ₩-0.3bn +₩0.6bn ₩-0.2bn
2026-08-31 ₩20,400 +₩0.4bn ₩-0.1bn ₩-0.3bn
2026-08-28 ₩19,840 +₩0.1bn +₩0.4bn ₩-0.3bn
2026-08-27 ₩19,300 ₩-0.2bn +₩0.8bn ₩-0.2bn
2026-08-26 ₩19,300 ₩-0.1bn +₩0.3bn ₩-0.2bn
2026-08-25 ₩18,970 +₩0.1bn +₩0.4bn ₩-0.4bn
2026-08-24 ₩18,450 +₩0.9bn +₩0.2bn ₩-1.0bn
2026-08-21 ₩17,010 ₩-0.1bn ₩-3.1bn +₩3.1bn
2026-08-20 ₩19,500 +₩1.0bn ₩-1.0bn ₩-0.0bn
2026-08-19 ₩19,060 ₩-0.6bn ₩-0.6bn +₩1.1bn
2026-08-18 ₩20,550 ₩-0.5bn +₩0.2bn +₩0.3bn
2026-08-14 ₩21,050 +₩0.1bn ₩-0.8bn +₩0.6bn
2026-08-13 ₩20,850 ₩-0.2bn ₩-0.4bn +₩0.5bn
2026-08-12 ₩22,750 ₩-0.9bn ₩-0.0bn +₩0.9bn
2026-08-11 ₩24,200 ₩-0.6bn +₩0.8bn ₩-0.1bn
2026-08-10 ₩23,400 +₩0.8bn +₩0.0bn ₩-0.9bn
2026-08-07 ₩21,650 ₩-0.1bn ₩-0.3bn +₩0.3bn
2026-08-06 ₩21,900 +₩0.0bn +₩0.8bn ₩-0.7bn
2026-08-05 ₩20,100 +₩0.4bn +₩0.0bn ₩-0.0bn
2026-08-04 ₩20,250 +₩0.6bn ₩-0.4bn ₩-0.3bn
2026-08-03 ₩18,720 +₩1.0bn ₩-1.0bn +₩0.0bn
2026-07-31 ₩18,600 +₩0.4bn ₩-0.6bn +₩0.2bn
2026-07-30 ₩18,040 ₩-0.0bn +₩0.5bn ₩-0.4bn
2026-07-29 ₩17,310 +₩0.3bn ₩-0.2bn ₩-0.2bn
2026-07-28 ₩18,670 +₩1.0bn ₩-0.1bn ₩-0.8bn
2026-07-27 ₩19,100 +₩0.5bn ₩-0.5bn ₩-0.0bn
2026-07-24 ₩19,700 ₩-0.9bn +₩0.9bn +₩0.0bn
2026-07-23 ₩20,900 +₩0.9bn ₩-0.7bn ₩-0.3bn
2026-07-22 ₩20,600 ₩-0.3bn ₩-1.0bn +₩1.3bn
2026-07-21 ₩21,300 ₩-0.2bn +₩0.0bn +₩0.2bn
2026-07-20 ₩20,350 ₩-0.6bn ₩-0.7bn +₩1.4bn
2026-07-16 ₩22,900 ₩-0.3bn ₩-1.1bn +₩1.4bn

Investor flows summary

Window Foreign (USD) Institutions Retail
1 day +₩0.9bn +$1M +₩1.9bn ₩-2.7bn
5 days +₩0.2bn +$0M +₩1.8bn ₩-2.2bn
20 days +₩0.1bn +$0M +₩3.7bn ₩-3.7bn

Positive = net buying, negative = net selling. Values aggregate the KRX main board and the NXT alternative venue.

Frequently asked questions

Are foreign investors buying Hans Biomed stock?

Over the last 5 sessions foreign investors net bought ₩0.2bn ($0M) of Hans Biomed; over 60 sessions they net bought ₩1.2bn ($1M); since Jan 1, 2026 they net bought ₩3.0bn ($2M). Over 20 sessions the stock is the 557th largest foreign net purchase among 1828 KOSDAQ stocks.

How much of Hans Biomed do foreign investors own?

Foreign investors own 6% of Hans Biomed's shares as of Oct 16, 2026, versus 2.19% one year earlier. The figure is KRX's daily foreign holdings divided by listed shares, and it reflects trades settled through the previous session.

Who is on the other side — institutions or retail investors?

Over 20 sessions institutions net bought ₩3.7bn ($3M) and retail investors net sold ₩3.7bn ($3M) of Hans Biomed. Retail investors have been supplying the shares that foreigners and institutions are buying.

Is Hans Biomed listed on KOSPI or KOSDAQ?

Hans Biomed (한스바이오메드) trades on KOSDAQ under KRX code 042520 in the Biotech & Pharma group, with a market capitalization of ₩0T ($0.2B). Daily net flows by investor type are published by KRX after each session and combine the KRX main board with the NXT venue.

Annual financials

Fiscal year Revenue YoY Operating profit Net income
2023 ₩78bn ($58M) – -₩4bn (-$3M) -₩24bn (-$18M)
2024 ₩81bn ($60M) +4.00% ₩1bn ($0M) -₩8bn (-$6M)
2025 ₩90bn ($67M) +10.70% -₩26bn (-$19M) -₩32bn (-$24M)

Consolidated (K-IFRS) where available, from DART regulatory filings. USD figures converted at the current rate (₩1345.9/$) for reference only.

← All foreign investor flows